Quantessence Capital’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-425
Closed -$201K 95
2026
Q1
$201K Buy
+425
New +$214K 0.98% 50
2025
Q4
Sell
-9,343
Closed -$3.98M 78
2025
Q3
$3.98M Sell
9,343
-338
-3% -$131K 1.26% 20
2025
Q2
$3.71M Buy
9,681
+6,181
+177% +$2.23M 1.09% 16
2025
Q1
$1.21M Buy
3,500
+2,147
+159% +$691K 0.3% 73
2024
Q4
$406K Buy
+1,353
New +$473K 0.17% 135

Other funds holding HCA

Quantessence Capital's HCA Position: Q2 2026 in Review

Quantessence Capital sold out of HCA Healthcare (HCA) in Q2 2026, closing a stake of 425 shares — an estimated $201K sold.

Quantessence Capital first reported a position in HCA in Q4 2024 and held it in 5 quarters. The position peaked at $3.98M in Q3 2025. 1,331 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • Quantessence Capital reported no remaining HCA Healthcare position as of Q2 2026 after selling out during the quarter.
  • Quantessence Capital sold 425 HCA Healthcare shares in Q2 2026, an estimated $201K.
  • Quantessence Capital first reported a position in HCA Healthcare in Q4 2024 and held it in 5 quarters.
  • Quantessence Capital's HCA Healthcare position peaked at $3.98M in Q3 2025.
  • 1,331 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on Quantessence Capital's 13F filing for Q2 2026, filed 14 Aug 2026.